Found: 5
Select item for more details and to access through your institution.
Peanut oral immunotherapy may improve health‐related quality of life among severe peanut allergic adolescents.
- Published in:
- Clinical & Translational Allergy, 2023, v. 13, n. 2, p. 1, doi. 10.1002/clt2.12225
- By:
- Publication type:
- Article
Transcriptome changes during peanut oral immunotherapy and omalizumab treatment.
- Published in:
- Pediatric Allergy & Immunology, 2022, v. 33, n. 1, p. 1, doi. 10.1111/pai.13682
- By:
- Publication type:
- Article
Individually dosed omalizumab facilitates peanut oral immunotherapy in peanut allergic adolescents.
- Published in:
- Clinical & Experimental Allergy, 2019, v. 49, n. 10, p. 1328, doi. 10.1111/cea.13469
- By:
- Publication type:
- Article
A pilot study towards the immunological effects of omalizumab treatment used to facilitate oral immunotherapy in peanut‐allergic adolescents.
- Published in:
- Scandinavian Journal of Immunology, 2021, v. 93, n. 4, p. 1, doi. 10.1111/sji.13005
- By:
- Publication type:
- Article
IgE to novel citrus seed allergens among cashew-allergic children.
- Published in:
- Pediatric Allergy & Immunology, 2016, v. 27, n. 5, p. 550, doi. 10.1111/pai.12553
- By:
- Publication type:
- Article